The Role of Retinyl Acetate in Chemoprevention

Aydin O^1, , Akyuz F¹, Tekin N², Burukoglu D³, Ozden H⁴, Ustuner MC⁵ and Degirmenci I⁵

¹Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

²Department of Biochemistry, Chemistry Division, Faculty of Science, Aksaray University, Aksaray, Turkey

³Department of Histology and Embryology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

⁴Department of Anatomy, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

⁵Department of Medical Biology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

Cite this paper:
Aydin O, Akyuz F, Tekin N, Burukoglu D, Ozden H, Ustuner MC and Degirmenci I. The Role of Retinyl Acetate in Chemoprevention. Journal of Food and Nutrition Research. 2014; 2(1):9-16. doi: 10.12691/jfnr-2-1-2

Abstract

Retinoids have a role in the process of chemoprevention. They can inhibit promotion through inhibiting cell proliferation, enhancing apoptosis and anti-oxidative properties. In the present study initiative-p-dimethylaminoazobenzene (p-DAB) and promotive- 2, 3, 7, 8-Tetrachlorodibenzo-p-Dioxin (TCDD) was given to the rats subchronically. It was aim to evaluate the effects on the apoptosis and lipid peroxidation of Retinyl Acetate in the liver and to determine the plasma levels of Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinase-2 (MMP-2) different fixation intervals called as 30, 60, 90 and 120. Apoptosis was determined with assays of Cytochrome c release and DNA fragmentation. Preneoplastic changes in the liver tissues were evaluated histopathologically. In p-DAB+TCDD group there were a decrease apoptosis and an increase lipid peroxidation, VEGF levels and preneoplastic changes beginning from day 60. The increase of MMP-2 levels was shown at day 90 and 120. There was an increase in the apoptosis and also decrease in the lipid peroxidation and levels of VEGF in the Retiniyl Acetate treated rats compare to p-DAB+TCDD group at day 60, 90, and 120. Mild preneoplastic changes and decreased MMP-2 were also observed only at day 120. Retinyl acetate may affect the stages of promotion that appeared preneoplastic changes via inducing apoptosis, reducing lipid peroxidation in the liver and decreasing levels of pro-angiogenic molecule VEGF and pro-invasive molecule MMP-2.

Keywords:
p-dimethylaminoazobenzene TCDD chemoprevention retinyl acetate liver

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Mestre, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., Dannenberg, A. J.,” Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2,” Cancer Research, 57(6).1081-1085. Mar. 1997.
[2]	Groff, J. L., Gropper, S.S., Hunt, S. M., The Fat Soluble Vitamins. In Advanced Nutrition and Human Metabolism, West Publishing Company, Minneapolis, 1995, 284-324.
[3]	Perusek, L., Maeda, T., “Vitamin A derivatives as treatment options for retinal degenerative diseases,” Nutrients, 5(7). 2646-2666. Jul. 2013.
[4]	Lotan, R., “Retinoids in cancer chemoprevention,” FASEB Journal, 10 (9). 1031-1039. Jul. 1996.
[5]	Zaman, Z., Fielden, P., Frost, P. G., “Simultaneous determination of vitamins A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects,” Clinical Chemistry, 39 (11 Pt 1). 2229-2234. Nov. 1993.
[6]	Fonseca, E. M. de A. V., Chagas, C. E. A., Mazzantini, R. P., Heidor, R., Ong, T. P., and Moreno, F. S., “All-trans and 9-cis retinoic acids, retinol and b-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage,” Carcinogenesis, 26. 1940-1946. 2005.
[7]	Walaszek, Z., Hanausek, M., Slaga, T.J., “Mechanisms of chemoprevention,” Chest, 125 (5 Suppl). 128S-133S. May. 2004.
[8]	Thangapazham, R. L., Sharma, A., Maheshwari, R. K., “Multiple molecular targets in cancer chemoprevention by curcumin,” The AAPS Journal, 8 (3). E 443-449. Jul. 2006.
[9]	Tsao, A. S., Kim, E. S., Hong, W. K., “Chemoprevention of cancer,” CA: A Cancer Jounal for Clinicians, 54 (3). 150-180. May. - Jun. 2004.
[10]	Malaguarnera, G., Cataudella, E., Giordano, M., Nunnari, G., Chisari, G., Malaguarnera, M., “Toxic hepatitis in occupational exposure to solvents,” World Journal of Gastroenterology, 18 (22). 2756-2766. Jun. 2012.
[11]	Gopal, R., Gnanamani, A., Udayakumar, R., Sadulla, S., “Enicostemma Littorale Blume- A potential hypolipidemic plant,” Natural Product Radiance, 3. 401-405. 2004.
[12]	Biswas, S. J. and Khuda-Bukhsh, A. R., “Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzene in mice: A time-course study,” Mutation Research, 587 (1-2). 1-8. Nov. 2005.
[13]	Bhattacharjee, N., Pathak, S., Khuda-Bukhsh, A. R., “Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200,” Evidence- Based Complementary and Alternative Medicine, 6 (1). 65-75. Mar. 2009.
[14]	Mishra, D., Sudarshan. M., Chakraborty. A., “Elemental alteration, iron overloading and metallothionein induction in experimental hepatocarcinogenesis: a free radical-mediated process?,” Toxicology Letters, 203(1). 40-47. May. 2011.
[15]	Biswas, S. J., Bhattacharjee, N., Khuda-Bukhsh, A. R., “Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice,” Food and Chemical Toxicololgy, 46 (5). 1474-1487. May. 2008.
[16]	Pathak, S., Kumar Das, J., Biswas, S. J., Khuda-Bukhsh, A. R., “Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice,” Molecular and Cellular Biochemistry, 285 (1-2). 121-131. Apr. 2006.
[17]	Shertzer, H. G., Genter, M. B., Shen, D., Nebert, D. W, Chen, Y., Dalton, T. P., “TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone,” Toxicology and Applied Pharmacolology, 217 (3). 363-374. Dec. 2006.
[18]	El Gendy, M.A., El-Kadi, A.O., “Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice,” Biomed Research International, 2013. 258095. 2013.
[19]	Viluksela, M., Bager, Y., Tuomisto, J. T., Scheu, G., Unkila, M., Pohjanvirta, R., Flodstrom, S., Kosma, V. M., Maki-Paakkanen, J., Vartiainen, T., Klimm, C., Schramm, K. W., Warngard, L., Tuomisto, J., “Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant Rat Strains,” Cancer Research, 60 (24). 6911-6920. Dec. 2000.
[20]	Sills, R. C., Goldsworthy, T. L., Sleight, S.D., “Tumor-promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weanling Sprague-Dawley rats: a quantitative, phenotypic, and ras p21 protein study,” Toxicologic Pathology, 22 (3). 270-281. May. 1994.
[21]	Slezak, B. P., Diliberto, J. J., Birnbaum, L. S., “2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Oxidative Stress in CYP1A2 Knockout (CYP1A22/2) Mice,” Biochemical and Biophysical Research Communications, 264 (2). 376-379. Oct. 1999.
[22]	Mann, P.C., “Selected lesions of dioxin in laboratory rodents,” Toxicologic Pathology, 25 (1). 72-79. Jun-Feb. 1997.
[23]	Pitot, H. C., Campbell, H. A., “An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat,” Environmental Health Perspectives, 76. 49-56. Dec. 1987.
[24]	Dragan, Y. P., Xu, X. H., Goldsworthy, T. L., Campbell, H. A., Maronpot, R.R., Pitot, H. C., “Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat,” Carcinogenesis, 13 (8). 1389-1395. Aug. 1992.
[25]	Wyde, M.E., Cambre, T., Lebetkin, M., Eldridge, S.R., Walker, N.J., “Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats,” Toxicological Sciences, 68 (2). 295-303. Aug. 2002.
[26]	Kociba, R.J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D.A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S.D., Hummel, R.A., Humiston, C.G., “Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats,” Toxicology and Applied Pharmacology, 46 (2). 279-303. Nov. 1978.
[27]	Villano, C. M., Murphy, K. A., Akintobi, A., White, L., “2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells,” Toxicology and Applied Pharmacology, 210 (3). 212-224. Feb. 2006.
[28]	Soeda, J., Miyagawa, S., Sano, K., Masumoto, J., Taniguchi, S., Kawasaki, S., “Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver,” American Journal of Physiology. Gastrointestinal and Liver Physiology, 281(4). 1115-1123. Oct. 2001.
[29]	Bradford, M.M., “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analitical Biochemistry, 72. 248. May. 1976.
[30]	Aw, T. Y., Nicotera, P., Manzo, L., Orrenius, S., “Tributyltin stimulates apoptosis in rat thymocytes,” Archives of Biochemistry and Biophysics, 283 (1). 46-50. Nov. 1990.
[31]	Noda, T., Iwakiri, R., Fujimoto, K., Matsuo, S., Aw, T. Y., “Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa,” The American Journal of Physiology, 274 (2 Pt 1). 270-276. Feb. 1998.
[32]	Burton, K., “A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid,” The Biochemical Journal, 62 (2). 315-323. Feb. 1956.
[33]	Ohkawa, H., Ohishi, W., Yzxagi, K., “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, 95 (2). 351-358. Jun. 1979.
[34]	Libbrecht, L., Desmet, V., Roskams, T., “Preneoplastic lesions in human hepatocarcinogenesis,” Liver International, 25 (1).16-27. Feb. 2005.
[35]	Murugan, R. S., Uchida, K., Hara, Y., Nagini, S.D., “Black tea polyphenols modulate xenobiotic-metabolizing enzymes, oxidative stress and adduct formation in a rat hepatocarcinogenesis model,” Free Radical Research, 42 (10), 873-884. Oct. 2008.
[36]	Bukhari, M. H., Qureshi, S.S., Niazi, S., Asef, M., Naheed, M., Khan, S.A., Chaudhry, N. A., Tayyab, M., Hasan, M., “Chemotherapeutic/chemopreventive role of retinoids in chemically induced skin carcinogenesis in albino mice,” Internatonal Journal of Dermatology, 46 (11). 1160-1165. Nov. 2007.
[37]	de Conti, A., Kuroiwa-Trzmielina, J., Horst, M.A., Bassoli, B. K., Chagas, C. E., Purgatto, E., Cavalher, F. P., Camargo, A. A., Jordão, A. A. Jr., Vannucchi, H., Scolastici, C., Ong, T. P., Moreno, F. S., “Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis,” The Journal of Nutritional Biochemistry, 23(8). 860-866. Aug. 2012.
[38]	Fletcher, N., Giese, N., Schmidt, C., Stern, N., Lind, P.M., Viluksela, M., Tuomisto, J. T., Tuomisto, J., Nau, H., Hakansson, H. “Altered Retinoid Metabolism in Female Long-Evans and Han/Wistar Rats following Long-Term 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Treatment,” Toxicological Sciences, 86 (2). 264-272. Aug. 2005.
[39]	Yang, Y. M., Huang, D. Y., Liu, G. F., Zhong, J.C., Du, K., Li, Y. F., Song, X. H., “Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice,” Journal of Biochemical and Molecular Toxicology,19 (5). 327-335. 2005.
[40]	Guajardo, M., Terrasa, A., Catala, A., “The effect of alpha tocopherol, all-trans retinol and retinyl palmitate on the non-enzymatic lipid peroxidation of rod outer segments,” Molecular and Cellular Biochemistry, 197 (1-2). 173-178. Jul. 1999.
[41]	Chakraborty, J.B., Oakley, F., Walsh, M. J., “Mechanisms and biomarkers of apoptosis in liver disease and fibrosis,” International Journal of Hepatology, 2012. 648915. 2012.
[42]	Worner, W., Schrenk, D., “Influence of Liver Tumor Promoters on Apoptosis in Rat Hepatocytes Induced by 2-Acetylaminofluorene, Ultraviolet Light, or Transforming Growth Factor β1,” Cancer Research, 56 (6). 1272-1278. Mar. 1996.
[43]	Lee, H.J., Lee, S.A., Choi, H., “Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis,” Asian Pacific Journal of Cancer Prevention, 6 (1). 41-47. Jan.-Mar. 2005.
[44]	Pettersson, F., Dalgleish, A.G., Bissonnette, R. P., Colston, K. W., “Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax,” British Journal of Cancer, 87 (5). 555-561. Aug. 2002.
[45]	Ozeki, A., Tsukamoto, I., “Retinoic acid repressed the expression of c-fos and c-jun and induced apoptosis in regenerating rat liver after partial hepatectomy,” Biochimica et Biophysica Acta, 1450 (3). 308-319. Jul. 1999.
[46]	Ioannou, Y. A., Chen, F. W., “Quantitation of DNA fragmentation in apoptosis,” Nucleic Acids Research, 24 (5). 992-993. Mar. 1996.
[47]	Shu, L., Cheung, K. L., Khor, T. O., Chen, C., Kong, A. N., “Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis,” Cancer Metastasis Reviews, 29 (3). 483-502. Sep. 2010.
[48]	Taniguchi, E., Sakisaka, S., Matsuo, K., Tanikawa, K., Sata, M., “Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats,” The Journal of Histochemistry and Cytochemistry, 49 (1). 121-130. Jan. 2001.
[49]	Walczak, R., Joseph, S. B., Laffitte, B.A., Castrillo, A., Pei, L., Tontonoz, P., “Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors,” The Journal of Biological Chemistry, 279 (11). 9905-9911. Mar. 2004.
[50]	Terman, B. I., Stoletov, K. V., “VEGF and Tumor Angiogenesis,” The Einstein Quarterly Journal of Biology and Medicine, 18. 59-66. 2001.
[51]	Vucenik, I., Passaniti, A., Vitolo, M. I., Tantivejkul, K., Eggleton, P., Shamsuddin, A.M., “Anti-angiogenic activity of inositol hexaphosphate (IP6),” Carcinogenesis, 25 (11). 2115-2123. Nov. 2004.
[52]	Park, E. Y., Wilder, E. T., Lane, M.A., “Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels,” Nutrition and Cancer, 57 (1). 66-77. 2007.
[53]	Goldstone, H.M., Stegeman, J. J. “Molecular mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin cardiovascular embryotoxicity,” Drug Metabolism Reviews, 38 (1-2). 261-289. 2006.
[54]	Murugan, R. S., Vinothini, G., Hara, Y., Nagini, S., “Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model,” Anticancer Research, 29 (6). 2301-2305. Jun 2009.
[55]	Frost, P., Berlanger, E., Mysore, V., Hoang, B., Shi, Y., Gera, J., Lichtenstein, A., “Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis,” Journal of Oncology, 2013. 897025. 2013.
[56]	Ge, Y. L., Zhang, X., Zhang, J. Y., Hou, L., Tian, R. H., “The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells,” International Immunopharmacology 9 (4). 389-395. Apr. 2009.
[57]	Pal, S., Iruela-Arispe, M. L., Harvey, V. S., Zeng, H., Nagy, J. A., Dvorak, H.F., Mukhopadhyay, D., “Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade,” Microvascular Research, 60 (2). 112-120. Sep. 2000.